Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMSON trial
2015-004109-18Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin in hyperlipidemia and cardiac morbidity, sponsored by Imperial College London. Primary endpoint: Symptom scoring. Started Apr 2016; status: completed.
02
Drugs
atorvastatin
03
Conditions
hyperlipidemiacardiac morbidity
Beyond the preview
Go deeper on 2015-004109-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004109-18.